Association between urinary concentration of phthalate metabolites and impaired renal function in Shanghai adults

2019 ◽  
Vol 245 ◽  
pp. 149-162 ◽  
Author(s):  
Jingsi Chen ◽  
Xiaofeng Zhou ◽  
Han Zhang ◽  
Yueming Liu ◽  
Chen Cao ◽  
...  
Keyword(s):  
Renal Function ◽  
Impaired Renal Function ◽  
Urinary Concentration ◽  
Phthalate Metabolites

scholarly journals Relationships of Urinary Beta2- microglobulin in Neonates with Impaired Renal Function in Different Stages of Hypoxic Ischaemic Encephalopathy

2013 ◽  
Vol 37 (1) ◽  
pp. 22-26
Author(s):  
M Banerjee ◽  
SK Majumdar ◽  
Md Shahidullah
Keyword(s):  
Renal Function ◽  
Serum Creatinine ◽  
Impaired Renal Function ◽  
Large Scale ◽  
Perinatal Asphyxia ◽  
Conclusive Evidence ◽  
Stage Iii ◽  
Clinical Staging ◽  
Urinary Concentration ◽  
Case Group

Hypoxic Ischaemic Encephalopathy (HIE) is a sequelae of neonates suffering from severe perinatal asphyxia. It may also cause impaired renal function due to acute tubular necrosis followed by elevation of urinary concentration of certain low molecular weight proteins like ?2- microglobulin. This study was designed to evaluate the urinary ?2- microglobulin level in neonates with HIE patients those who have impaired renal function. This prospective case control study was carried out in the Neonatal unit of the department of Pediatrics and in the Labor ward of the department of Obstetrics and Gynecology Bangabandhu Sheik Mujib Medical University, Dhaka during the period of 1st July 2005 to 30th June 2006. This study was designed to estimate urinary ?2- micro globulin level in the asphyxiated newborn as well normal newborns to see any significant changes and to find out its relation with over all outcomes of newborns with perinatal asphyxia. In this study, 42 term newborn babies before 24 hours of age, those who failed to take spontaneous breathing within 5 minutes of the complete delivery were taken as cases and 40 healthy term newborns were taken as control. Asphyxiated newborns were divided into three groups depending on the sarnat and sarnat clinical staging of HIE. Mean±SD value of urinary ?-2- micro globulin in case group 4.1 ± 2.79 mg/l and in the control was 1.35 ± 1.08 mg/l. It shows significant (p<0.01) rise of urinary ?-2 micro globulin levels in case group. The degree of rise of urinary ?-2- micro globulin was related with the severity of HIE but blood urea and serum creatinine levels were not increased significantly in stage I and stage II except in stage III HIE patients. It was concluded from this study that raised urinary â2- microglobulin level may be related with HIE patients irrespective of clinical staging but serum creatinine and blood urea were found to be elevated only in stage III HIE patients. But to draw a conclusive evidence regarding relationship of urinary ?2 microglobulin with advance stages of HIE in neonates with impaired renal function require further large scale study. DOI: http://dx.doi.org/10.3329/bjch.v37i1.15348 BANGLADESH J CHILD HEALTH 2013; VOL 37 (1) : 22-26

Assessment of possible nephrotoxicity from iohexol in patients with normal and impaired renal function

1998 ◽  
Vol 39 (4) ◽  
pp. 362-367 ◽  
Author(s):  
Stefan Lundqvist ◽  
G. Holmberg ◽  
G. Jakobsson ◽  
F. Lithner ◽  
K. Skinningsrud ◽  
...  
Keyword(s):  
Renal Function ◽  
Impaired Renal Function

Impaired renal function is an independent risk factor for complications after surgery for femoral neck fracture

2021 ◽  
pp. 112070002110285
Author(s):  
Pradip Ramamurti ◽  
Safa C Fassihi ◽  
David Sacolick ◽  
Alex Gu ◽  
Chapman Wei ◽  
...  
Keyword(s):  
Renal Function ◽  
Risk Factor ◽  
Femoral Neck ◽  
Femoral Neck Fracture ◽  
Impaired Renal Function ◽  
Independent Risk Factor ◽  
Femoral Neck Fractures ◽  
Stage 4 ◽  
Ckd Stage ◽  
Neck Fracture

Background: The metabolic abnormalities that occur secondary to chronic kidney disease (CKD) increase the risk of femoral neck fractures compared to the general population. The purpose of this study is to determine whether impaired renal function is an independent risk factor for complications after surgery for femoral neck fracture. Methods: The ACS-NSQIP database was reviewed for patients who underwent total hip arthroplasty, hemiarthroplasty and open reduction internal fixation (ORIF) for femoral neck fractures between 2007 and 2018. Patients were split into cohorts based on calculated estimated glomerular filtration rate. Demographic information, comorbidities, and 30-day complications were analysed with univariate and multivariate analyses using chi-square, Fischer’s exact and analysis of variance testing. Results: The total number of patients for the study was 163,717. Patients with CKD stage 4 and 5 had an increased rate of any complication (39.1 and 36.7% respectively) compared with higher eGFRs ( p  < 0.001). Similarly, 30-day mortality was increased at 6.0% and 6.7% for both stage 4 and 5 ( p  < 0.001). By multivariate regression, those with CKD Stage 4 and 5 were at increased risk for any complication compared to patients with a normal preoperative eGFR of 90–120 ( p  < 0.001). Conclusions: This study demonstrated that patients with CKD Stage 4 and 5 are at increased risks of all complications, including death, renal, pulmonary and thromboembolic disease. Therefore, these patients should be cared for from a multidisciplinary approach with close attention to postoperative medications and fall prevention to help mitigate the risk of complications in the immediate postoperative period.

125 Increased plasma renin activity during wake in a repetitive sleep restriction protocol

SLEEP ◽  
2021 ◽  
Vol 44 (Supplement_2) ◽  
pp. A51-A51
Author(s):  
Huan Yang ◽  
Michael Vazquez ◽  
Monika Haack ◽  
Janet Mullington
Keyword(s):  
Renal Function ◽  
Plasma Renin Activity ◽  
Impaired Renal Function ◽  
Plasma Renin ◽  
Renin Activity ◽  
Sleep Restriction ◽  
Science Center ◽  
Percent Change ◽  
Recovery Sleep ◽  
Increased Risk

Abstract Introduction Insufficient sleep is associated with an increased risk of hypertension. It is well established that long-term BP regulation is modulated by the renin-angiotensin-aldosterone system (RAAS) and chronic kidney disease is a strong independent risk factor for development of cardiovascular disease. This study investigated the biomarkers of RAAS and renal function during repetitive exposures to controlled, experimental sleep restriction (SR). We hypothesized an upregulation of RAAS and increased markers of impaired renal function. Methods Twenty-one healthy participants (11 women, average age 31±2 years) completed the 22-day in-hospital SR protocol: permitted 4h of sleep/night from 0300-0700 for 3 nights followed by a recovery sleep, repeated 4 times. Blood samples were collected and plasma renin activity (PRA) was assessed in the morning (7:05am) and in the evening before bedtime (22:45pm) at baseline, experimental days (3rd day of each of the 4 blocks), and recovery. Urinary albumin to creatinine ratio (ACR) was measured from 24-h urinary collection at baseline, first and fourth SR blocks. Estimated glomerulus filtration rate (eGFR) was calculated based on the serum cystatin C levels at baseline and last block of SR. Results Percent change of evening PRA significantly increased during 4 blocks of SR and recovery (SR effect p=0.039), but not morning PRA (SR effect p=0.34). Specifically, evening PRA increased up to 98.4% in the first (p&lt;0.01), 61.3% in the second (p=0.04) SR blocks, and 57.5% (p=0.05) in recovery. Urinary ACR showed no significant changes during first or fourth SR blocks (SR effect p=0.28). In addition, eGFR did not change in the fourth SR block compared to BL (paired t-test, p=0.27). Conclusion We did not see increased markers of impaired renal function (ACR or eGFR). Rather, short-term repetitive exposures to SR significantly increased percent change of PRA measured before bedtime, and evening PRA did not return to BL level during recovery. Our results suggested that sleep deficiency may contribute to hypertension through upregulation of RAAS during wake time. Support (if any) SRSF (CDA to Huan Yang), NIH (R01HL106782 to Dr. Janet Mullington), Harvard Catalyst, Harvard Clinical and Translational Science Center (UL1TR001102).

Sign in / Sign up

Export Citation Format

Share Document